Loading...
OTCM
CHHE
Market cap6kUSD
Nov 10, Last price  
0.00USD
Name

China Health Industries Holdings Inc

Chart & Performance

D1W1MN
OTCM:CHHE chart
P/E
P/S
0.06
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
-55.72%
Revenues
112k
+41,689.89%
747,064842,139763,59910,968,00043,106,00062,780,00058,936,0007,727,0009,709,00010,226,0527,817,0006,372,0006,555,0009,275,0009,932,0006,493,000267111,579
Net income
-409k
L+15.54%
-382,000-165,550-34,8982,824,00013,254,00017,674,00014,475,000-553,000-658,0002,561159,6021,312,000-317,0003,307,0003,551,0001,291,000-354,000-409,000
CFO
-42m
L
-205,505-71,729-91,4137,051,4809,515,6219,344,47320,892,290-10,489,376-1,353,1652,142,1401,888,4141,075,0202,989,3865,115,3852,404,9785,556,6942,115,726-42,272,498

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Operating through its various subsidiaries, China Health Industries Holdings, Inc. specializes in the production and distribution of a comprehensive array of health-oriented goods. Its product portfolio features numerous hemp-derived items, including hemp oil, protein powders, polypeptides, and a selection of skincare solutions like essence repair lotions, revitalizing essences, anti-aging brightening eye creams, and nourishing creams designed to combat signs of aging. The company also supplies dietary supplements, such as the QunLe brand's Sailuozhi soft capsules, which combine frog oil, soybean isoflavone, procyanidine, and vitamin E to help reduce freckles and enhance skin moisture. Another key offering is the Kindlink brand's propolis and black ant capsules, formulated with propolis, black ant, acanthopanax, and astragalus root. Beyond these, China Health Industries provides a range of health products addressing specific concerns like acne treatment, relief from eye strain, boosting bone density, improving memory, combating nutritional anemia and chloasma, promoting digestive health and lead detoxification, bolstering immunity, alleviating physical fatigue, and diminishing chloasma, alongside essential iron and multi-vitamin and mineral supplements. Additionally, the firm is involved in the manufacturing and sale of various medical drugs. The distribution of its extensive product line is primarily managed through a network of sales agents. China Health Industries Holdings, Inc. maintains its base of operations in Harbin City, People's Republic of China.
IPO date
Dec 01, 2004
Employees
45
Domiciled in
CN
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT